Subclassifications Of Assets, Liabilities And Equities [Abstract]

ABIONYX Pharma - Filing #2821124

Concept	As at 2020-12-31	As at 2020-01-01	As at 2019-12-31	As at 2019-01-01
Subclassifications of assets, liabilities and equities [abstract]
Property, plant and equipment [abstract]
Property, plant and equipment	91,000 EUR	—	10,000 EUR	—
Intangible assets and goodwill [abstract]
Intangible assets and goodwill	45,000 EUR	—	0 EUR	—
Miscellaneous non-current assets [abstract]
Other non-current assets	95,000 EUR	—	31,000 EUR	—
Trade and other receivables [abstract]
Trade receivables	0 EUR	—	0 EUR	—
Classes of current inventories [abstract]
Current inventories	0 EUR	—	0 EUR	—
Classes of current inventories, alternative [abstract]
Cash and cash equivalents [abstract]
Cash and cash equivalents	9 154 EUR	8 331 EUR	8 331 EUR	11 457 EUR
Miscellaneous current assets [abstract]
Other current assets	879,000 EUR	—	1 794 EUR	—
Borrowings [abstract]
Non-current portion of non-current borrowings	0 EUR	—	0 EUR	—
Non-current portion of non-current borrowings, by type [abstract]
Trade and other current payables [abstract]
Trade and other current payables	2 411 EUR	—	1 257 EUR	—
Categories of current financial liabilities [abstract]
Current financial liabilities	0 EUR	—	1 100 EUR	—
Miscellaneous non-current liabilities [abstract]
Other non-current liabilities	0 EUR	—	0 EUR	—
Miscellaneous current liabilities [abstract]
Other current liabilities	232,000 EUR	—	118,000 EUR	—
Issued capital [abstract]
Issued capital	1 232 EUR	—	1 097 EUR	—
Accumulated other comprehensive income [abstract]
Reserve of exchange differences on translation	39,000 EUR	—	92,000 EUR	—
Net assets (liabilities) [abstract]
Assets	10 288 EUR	—	10 249 EUR	—
Net current assets (liabilities) [abstract]
Current assets	10 033 EUR	—	10 125 EUR	—
Current liabilities	3 598 EUR	—	3 466 EUR	—
Assets less current liabilities [abstract]